Nalinda Wasala, Ph.D.

Translational Medicine Lead at Epic Bio
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
South San Francisco, California, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Translational Medicine Lead
      • Jun 2023 - Present

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Scientist II, Gene Editing Innovation Center
      • Sep 2020 - May 2023

    • United States
    • Higher Education
    • 200 - 300 Employee
    • Postdoctoral Fellow
      • Aug 2016 - Sep 2020

      I lead multiple research projects related to gene therapy development for DMD. These include studying the therapeutic potential of long-term CRISPR genome editing, evaluating SERCA2a gene therapy as a novel dystrophin-independent approach to improve calcium handling in the dystrophic heart, and evaluating novel synthetic dystrophin genes for heart-protective properties.

    • Graduate Research Assistant
      • Mar 2011 - Jul 2016

      I led multiple research projects to answer several fundamental questions related to DMD gene therapy. Specifically, I studied (1) whether selective replacement of dystrophin in skeletal muscle has unsought cardiac consequences (2) whether transient dystrophin expression is sufficient to provide long-term therapeutic benefit, (3) structure-function relationship of engineered dystrophin in the heart to identify cardioprotective dystrophin domains and (4) therapeutic potential of low-level dystrophin expression in the heart. Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant
      • Aug 2007 - Jul 2010

      I studied the identification and characterized the full-length cDNA sequence of the macrophage migration inhibitory factor (MIF) from the American dog tick. The nucleotide and putative amino acid sequences from this study shared a high level of sequence conservation with other tick MIFs. MIF has been identified from many organisms including mammals, nematodes, arthropods, jawed/ jawless fish, plants, cyanobacteria, and parasites. The bioinformatics analysis showed the across species conservation of the MIF amino acid sequence in ticks, nematodes, and insects. My research studies identified the upregulation of the MIF gene expression during 0-96 hrs fed female ticks. I also studied the effects of RNAi mediated gene silencing of MIF and subsequent effects on blood meal acquisition. Show less

    • Sri Lanka
    • Higher Education
    • 700 & Above Employee
    • Teaching Assistant
      • Jul 2005 - Jul 2007

Education

  • University of Missouri-Columbia, School of Medicine
    Doctor of Philosophy (Ph.D.), Gene/Genetic Therapy for Duchenne Muscular Dystrophy
    2010 - 2016
  • Oklahoma State University
    Master of Science - MS, Entomology
    2007 - 2010
  • University of Colombo
    Bachelor of Science - BS, Biochemistry and Molecular Biology
    2001 - 2005

Community

You need to have a working account to view this content. Click here to join now